International Endeavors Corp. announced that the Company has signed an MOU with Kubby Cryogenics Inc. Under the terms of this agreement, Kubby Cryogenics will look to patent medical grade cannabis strains that are genetically profiled to treating specific diseases. The company will be acquiring licensing rights to patent new delivery systems in the future. Further, the company will continue with product development in their own proprietary Cryogenics line, which captures the highest medical value of any product known on the market.